Cargando…
B cell aplasia and hypogammaglobulinemia associated with levetiracetam
Levetiracetam (LEV) is a second-generation antiepileptic drug approved for the treatment of several types of epilepsy. We report a 45-year-old female who developed hypogammaglobulinemia and B cell aplasia during LEV treatment. The Naranjo probability score for an adverse drug reaction was 6. After L...
Autores principales: | Ozdemir, Hulya, Sumer, Sua, Karabagli, Hakan, Akdemir, Gokhan, Caliskaner, A. Zafer, Artac, Hasibe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074184/ https://www.ncbi.nlm.nih.gov/pubmed/29313528 http://dx.doi.org/10.5144/0256-4947.2018.09.01.1430 |
Ejemplares similares
-
Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020) -
Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019) -
Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022) -
Radiological Findings of Michel Aplasia
por: Umul, Ayse, et al.
Publicado: (2016) -
The alteration of lymphocyte subsets in idiopathic granulomatous mastitis
por: EMSEN, Ayça, et al.
Publicado: (2021)